ATORX 2,37 SEK (3,49 %) 02 Dec 2021 17:29 SV ABOUT ALLIGATOR RESEARCH & DEVELOPMENT CORPORATE GOVERNANCE INVESTORS NEWS CONTACT About Alligator Start > About Alligator Board of directors Management Collaborations and partnerships Career About Alligator Alligator is a research-based biotechnology company developing antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. In immunotherapy, the patients´ immune system is activated to cure cancer. The term tumor-directed means that the drug is administered or designed such that the pharmacological effect is localized to the tumor. This results in an advantageous efficacy and safety profile. The company is primarily active in the early phases of drug development, from the idea stage to clinical phase II trials. This includes identification of innovative modes of action for pharmaceuticals, producing and optimizing new drug candidates, evaluation of preclinical efficacy and safety, and finally confirmatory clinical studies in cancer patients. Alligator was founded in 2001 and is located at Medicon Village in Lund, Sweden. About Alligator develops antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. The company is active in the early stages of drug development, from idea to clinical phase II studies. Links About Alligator Research and development Corporate governance Investors News Contact Privacy policy Contact Alligator Bioscience AB Medicon Village Scheelevägen 2 SE-223 81 Lund Sweden Phone: + 46 (0)46 540 82 00 info@alligatorbioscience.com ir@alligatorbioscience.com Subscribe Subscribe to get our pressreleases by email. SUBSCRIBE © Copyright 2018 - Alligator Bioscience AB